Trypanosoma brucei gambiense Group 2: The Unusual Suspect.
Jamonneau V, Truc P, Grébaut P, Herder S, Ravel S, Solano P, De Meeus T.
Trends Parasitol. 2019 Dec;35(12):983-995. doi: 10.1016/j.pt.2019.09.002. Epub 2019 Oct 24.
Contemporary and emerging strategies for eliminating human African trypanosomiasis due to Trypanosoma brucei gambiense: review.
Steinmann P, Stone CM, Sutherland CS, Tanner M, Tediosi F.
Trop Med Int Health. 2015 Jun;20(6):707-18. doi: 10.1111/tmi.12483. Epub 2015 Mar 12.
Trypanosoma brucei gambiense-iELISA: A Promising New Test for the Post-Elimination Monitoring of Human African Trypanosomiasis.
Geerts M, Van Reet N, Leyten S, Berghmans R, Rock KS, Coetzer THT, Eyssen LE, Büscher P.
Clin Infect Dis. 2021 Nov 2;73(9):e2477-e2483. doi: 10.1093/cid/ciaa1264.
3 Tesla serial magnetic resonance imaging of human African trypanosomiasis (Trypanosoma brucei gambiense) and review of the literature.
Boukobza M, Lariven S, Houze S, Laissy JP.
Rev Neurol (Paris). 2021 Nov;177(9):1176-1182. doi: 10.1016/j.neurol.2020.11.002. Epub 2021 Feb 26.
Development of drug resistance in Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense. Treatment of human African trypanosomiasis with natural products (Review).
Gehrig S, Efferth T.
Int J Mol Med. 2008 Oct;22(4):411-9.
Identification of Trypanosoma brucei gambiense in naturally infected dogs in Nigeria.
Umeakuana PU, Gibson W, Ezeokonkwo RC, Anene BM.
Parasit Vectors. 2019 Aug 27;12(1):420. doi: 10.1186/s13071-019-3680-8.
Secreted proteases of Trypanosoma brucei gambiense: possible targets for sleeping sickness control?
Bossard G, Cuny G, Geiger A.
Biofactors. 2013 Jul-Aug;39(4):407-14. doi: 10.1002/biof.1100. Epub 2013 Mar 29.
Target product profile: Trypanosoma brucei gambiense test for low-prevalence settings.
Priotto G, Franco JR, Lejon V, Büscher P, Matovu E, Ndung'u J, Biéler S, Mumba D, Van Reet N, Verlé P, Jamonneau V, Simarro PP, Ebeja AK, Sankara D, Dagne DA.
Bull World Health Organ. 2023 Aug 1;101(8):541-545. doi: 10.2471/BLT.23.290176. Epub 2023 Jun 26.
The genome sequence of Trypanosoma brucei gambiense, causative agent of chronic human african trypanosomiasis.
Jackson AP, Sanders M, Berry A, McQuillan J, Aslett MA, Quail MA, Chukualim B, Capewell P, MacLeod A, Melville SE, Gibson W, Barry JD, Berriman M, Hertz-Fowler C.
PLoS Negl Trop Dis. 2010 Apr 13;4(4):e658. doi: 10.1371/journal.pntd.0000658.
Target product profile: diagnostic test for Trypanosoma brucei gambiense.
Priotto G, Franco JR, Lejon V, Büscher P, Matovu E, Ndung'u J, Biéler S, Mumba D, Van Reet N, Verlé P, Jamonneau V, Simarro PP, Ebeja AK, Sankara D, Dagne DA.
Bull World Health Organ. 2023 Aug 1;101(8):535-540. doi: 10.2471/BLT.23.290172. Epub 2023 Jun 15.
